Jesko P. Welters

Leiden, ZH 2333ZG, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Local immunosuppressive microenvironment underlies reduced responsiveness to imiquimod treatment in recurrent or residual cervical HSIL.

Local immunosuppressive microenvironment underlies reduced responsiveness to imiquimod treatment in recurrent or residual cervical HSIL.

Journal: Gynecologic oncology reports

Published: April 13, 2026

Prophylactic Intravenous Tranexamic Acid in Thoracic Surgery: A Matched-pair Analysis From the German Thoracic Registry.

Prophylactic Intravenous Tranexamic Acid in Thoracic Surgery: A Matched-pair Analysis From the German Thoracic Registry.

Journal: Journal of cardiothoracic and vascular anesthesia

Published: April 03, 2025

Correction: Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials.

Correction: Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials.

Journal: Leukemia

Published: March 30, 2025

Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy.

Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 28, 2025

Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials.

Correlation of progression-free survival and overall survival after treatment for relapsed Hodgkin lymphoma: individual patient data analysis of randomized German Hodgkin Study Group (GHSG) Trials.

Journal: Leukemia

Published: January 06, 2025

Fatal dengue virus infection in an unvaccinated traveler.

Fatal dengue virus infection in an unvaccinated traveler.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: October 06, 2024

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.

Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.

Journal: Journal for immunotherapy of cancer

Published: October 11, 2018

The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival.

The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival.

Journal: Oncoimmunology

Published: February 28, 2018

The presence of human papillomavirus (HPV) in placenta and/or cord blood might result in Th2 polarization.

The presence of human papillomavirus (HPV) in placenta and/or cord blood might result in Th2 polarization.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: January 16, 2017

The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer.

The identification of patients at high risk for recurrent disease after treatment for early-stage cervical cancer.

Journal: European journal of gynaecological oncology

Published: January 01, 2017

Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.

Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.

Journal: Oncoimmunology

Published: October 14, 2016

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 31, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026